Gemma Hancock

828 total citations
20 papers, 623 citations indexed

About

Gemma Hancock is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Gemma Hancock has authored 20 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Gemma Hancock's work include HIV Research and Treatment (11 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (5 papers). Gemma Hancock is often cited by papers focused on HIV Research and Treatment (11 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (5 papers). Gemma Hancock collaborates with scholars based in United Kingdom, Australia and Spain. Gemma Hancock's co-authors include Lucy Dorrell, Karin Hellner, Genevieve Clutton, Emma Wainwright, Stefan Neubauer, Brian Angus, Ntobeko Ntusi, Cameron Holloway, Kieran Clarke and Stefan K. Piechnik and has published in prestigious journals such as Circulation, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Gemma Hancock

19 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gemma Hancock United Kingdom 13 226 210 200 183 150 20 623
Ross A. Pollack United States 7 217 1.0× 795 3.8× 282 1.4× 33 0.2× 204 1.4× 8 1.0k
Sabine Allard Belgium 15 30 0.1× 176 0.8× 213 1.1× 46 0.3× 115 0.8× 52 655
L Boshkov Canada 9 168 0.7× 104 0.5× 77 0.4× 89 0.5× 145 1.0× 10 748
Nickolas Teigen United States 11 59 0.3× 730 3.5× 1.0k 5.2× 44 0.2× 194 1.3× 13 1.3k
Tzong‐Hae Lee United States 13 107 0.5× 505 2.4× 196 1.0× 15 0.1× 230 1.5× 18 914
Mariola López Spain 19 195 0.9× 503 2.4× 336 1.7× 16 0.1× 366 2.4× 39 950
Patricia Baré Argentina 16 43 0.2× 172 0.8× 173 0.9× 12 0.1× 228 1.5× 46 665
Rada Ellegård Sweden 14 18 0.1× 179 0.9× 275 1.4× 28 0.2× 143 1.0× 23 515
W. Heise Germany 15 86 0.4× 172 0.8× 100 0.5× 18 0.1× 258 1.7× 41 690
Mila Lebedeva United States 10 95 0.4× 495 2.4× 335 1.7× 9 0.0× 223 1.5× 10 801

Countries citing papers authored by Gemma Hancock

Since Specialization
Citations

This map shows the geographic impact of Gemma Hancock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma Hancock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma Hancock more than expected).

Fields of papers citing papers by Gemma Hancock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemma Hancock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma Hancock. The network helps show where Gemma Hancock may publish in the future.

Co-authorship network of co-authors of Gemma Hancock

This figure shows the co-authorship network connecting the top 25 collaborators of Gemma Hancock. A scholar is included among the top collaborators of Gemma Hancock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gemma Hancock. Gemma Hancock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Peng, Isaac Woodhouse, Gemma Hancock, et al.. (2023). Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer. iScience. 26(3). 106101–106101. 8 indexed citations
2.
Kopycinski, Jakub, Hongbing Yang, Gemma Hancock, et al.. (2023). Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions. Scientific Reports. 13(1). 17155–17155. 5 indexed citations
3.
Xu, Peng, Isaac Woodhouse, Gemma Hancock, et al.. (2022). Novel Canonical and Non-Canonical Antigens That Extend Current Targets for Immunotherapy of HPV-Driven Cervical Cancer. SSRN Electronic Journal.
4.
Hancock, Gemma, César López‐Camacho, Jakub Kopycinski, et al.. (2019). A multi-genotype therapeutic human papillomavirus vaccine elicits potent T cell responses to conserved regions of early proteins. Scientific Reports. 9(1). 18713–18713. 18 indexed citations
5.
Andreatta, Massimo, Annalisa Nicastri, Peng Xu, et al.. (2018). MS‐Rescue: A Computational Pipeline to Increase the Quality and Yield of Immunopeptidomics Experiments. PROTEOMICS. 19(4). e1800357–e1800357. 28 indexed citations
6.
Hancock, Gemma, Sara Morón‐López, Jakub Kopycinski, et al.. (2017). Evaluation of the immunogenicity and impact on the latent HIV‐1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy‐treated subjects. Journal of the International AIDS Society. 20(1). 21171–21171. 27 indexed citations
7.
Hancock, Gemma, Karin Hellner, & Lucy Dorrell. (2017). Therapeutic HPV vaccines. Best Practice & Research Clinical Obstetrics & Gynaecology. 47. 59–72. 82 indexed citations
8.
Yang, Hongbing, Sandrine Buisson, Giovanna Bossi, et al.. (2016). Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors. Molecular Therapy. 24(11). 1913–1925. 31 indexed citations
9.
Ntusi, Ntobeko, Lucy Dorrell, Emma Wainwright, et al.. (2016). HIV-1–Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema. Circulation Cardiovascular Imaging. 9(3). e004430–e004430. 83 indexed citations
10.
Hancock, Gemma, Hongbing Yang, Emma Wainwright, et al.. (2015). Identification of Effective Subdominant Anti-HIV-1 CD8+ T Cells Within Entire Post-infection and Post-vaccination Immune Responses. PLoS Pathogens. 11(2). e1004658–e1004658. 37 indexed citations
11.
Rider, Oliver J., Ntobeko Ntusi, Emma Wainwright, et al.. (2014). HIV is an independent predictor of aortic stiffness. Journal of Cardiovascular Magnetic Resonance. 16(1). 57–57. 30 indexed citations
12.
Yang, Hongbing, Gemma Hancock, Genevieve Clutton, et al.. (2013). Improved quantification of HIV-1-infected CD4+ T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection. Journal of Immunological Methods. 391(1-2). 174–178. 19 indexed citations
13.
Clutton, Genevieve, Hongbing Yang, Gemma Hancock, et al.. (2013). Emergence of a distinct HIV‐specific IL‐10‐producing CD8+T‐cell subset with immunomodulatory functions during chronic HIV‐1 infection. European Journal of Immunology. 43(11). 2875–2885. 4 indexed citations
14.
Holloway, Cameron, Ntobeko Ntusi, J. Suttie, et al.. (2013). Comprehensive Cardiac Magnetic Resonance Imaging and Spectroscopy Reveal a High Burden of Myocardial Disease in HIV Patients. Circulation. 128(8). 814–822. 150 indexed citations
15.
Wu, Hao, Gemma Hancock, Genevieve Clutton, et al.. (2012). The antiviral inhibitory capacity of CD8+T cells predicts the rate of CD4+cell decline in HIV-1 infection. HIV Medicine. 13. 6–6. 1 indexed citations
16.
Ahmed, Tina, Nicola Borthwick, Gemma Hancock, et al.. (2012). Recombinant DNA/MVA/ChAdV-63-elicited T cells specific for conserved regions of the HIV-1 proteome recognize HIV-1 infected cells and suppress HIV-1. Retrovirology. 9(S2). 1 indexed citations
17.
Yang, Hongbing, Hao Wu, Gemma Hancock, et al.. (2012). Antiviral Inhibitory Capacity of CD8+ T cells Predicts the Rate of CD4+ T-Cell Decline in HIV-1 Infection. The Journal of Infectious Diseases. 206(4). 552–561. 61 indexed citations
18.
Ahmed, Tina, Antony P. Black, Hongbing Yang, et al.. (2012). Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial. Retrovirology. 9(S2). 5 indexed citations
19.
Howles, Sarah, Ana Guimarães‐Walker, Hongbing Yang, et al.. (2010). Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects. Vaccine. 28(45). 7306–7312. 17 indexed citations
20.
Hancock, Gemma, C.R. Wilks, Michael Kotiw, & John Allen. (1984). The long term efficacy of a Hardjo‐pomona vaccine in preventing leptospiruria in cattle exposed to natural challenge with Leptospira interrogans serovar hardjo. Australian Veterinary Journal. 61(2). 54–56. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ross A. Pollack Breakdown of academic impact, for papers by Sabine Allard Breakdown of academic impact, for papers by L Boshkov Breakdown of academic impact, for papers by Nickolas Teigen Breakdown of academic impact, for papers by Tzong‐Hae Lee Breakdown of academic impact, for papers by Mariola López Breakdown of academic impact, for papers by Patricia Baré Breakdown of academic impact, for papers by Rada Ellegård Breakdown of academic impact, for papers by W. Heise Breakdown of academic impact, for papers by Mila Lebedeva
Rankless by CCL
2026